GRDN Stock Price Prediction 2026
Guardian Pharmacy Services, Inc.
AI-powered price predictions based on fundamental analysis and growth projections
- Moving averages converging - equilibrium state
- MACD converging near zero line - potential energy building
- Recent pattern: Doji - Indecision pattern
Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.
Volume Trend: Neutral
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
Options Analysis: 1-Year Target Strategy
Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).
The $40 call expiring Apr 17, 2026 costs $2.50. If GRDN reaches the 1-year growth target of $42.54, this option would be profitable with a 1.6% return.
Note: Options involve significant risk. Only invest what you can afford to lose.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $30.18 | -0.1% |
| 90 Days | $30.13 | -0.2% |
| 6 Months | $30.06 | -0.4% |
| 1 Year | $29.93 | -0.9% |
| 2 Years EXTENDED | $29.66 | -1.8% |
| 3 Years EXTENDED | $29.39 | -2.7% |
More GRDN Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results